Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C19H19N3 |
Molar mass | 289.382 g·mol−1 |
3D model ( JSmol) | |
| |
|
Perafensine ( INN) (code name HR-459) is a drug which was investigated as an antidepressant but was never marketed. [1] It has been reported to antagonize the effects of reserpine and to inhibit the reuptake of norepinephrine ( norepinephrine reuptake inhibitor); whether it also affects the reuptake of serotonin or dopamine is unclear. [2]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C19H19N3 |
Molar mass | 289.382 g·mol−1 |
3D model ( JSmol) | |
| |
|
Perafensine ( INN) (code name HR-459) is a drug which was investigated as an antidepressant but was never marketed. [1] It has been reported to antagonize the effects of reserpine and to inhibit the reuptake of norepinephrine ( norepinephrine reuptake inhibitor); whether it also affects the reuptake of serotonin or dopamine is unclear. [2]